Literature DB >> 24977691

ACR appropriateness Criteria® advanced stage endometrial cancer.

Mohamed A Elshaikh1, Catheryn M Yashar, Aaron H Wolfson, Higinia Rosa Cardenes, Beth Erickson, Anuja Jhingran, Shruti Jolly, Elizabeth Kidd, Larissa J Lee, Nina A Mayr, David Moore, Gautam G Rao, William Small, Mahesh A Varia, Andrew O Wahl, William Yuh, David K Gaffney.   

Abstract

OBJECTIVES: Patients with advanced stage endometrial carcinoma constitute a heterogeneous group of patients with different stages, tumor histologic types, and involved sites. Hysterectomy, bilateral salpingo-ophorectomy, and surgical staging are the cornerstone of surgical management in these patients. The optimal adjuvant therapy is yet to be established. An expert panel was convened to reach consensus on the most appropriate management options in this group of patients.
METHODS: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
RESULTS: Four clinical variants were developed to address common scenarios in the management of women with advanced-stage endometrial carcinoma. Group members reached consensus on the appropriateness of specific evaluation and treatment approaches with numerical ratings.
CONCLUSIONS: In combining available medical literature and expert opinions, this manuscript may serve as an aid for other practitioners in the appropriate management of women with advanced-stage endometrial carcinoma.

Entities:  

Mesh:

Year:  2014        PMID: 24977691     DOI: 10.1097/COC.0000000000000098

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  2 in total

1.  Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study.

Authors:  Ji Geun Yoo; Jin Hwi Kim; Chan Joo Kim; Hae Nam Lee; Min Jong Song; Dong Choon Park; Joo Hee Yoon; Sang Il Kim; Soo Young Hur; Sung Jong Lee
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

2.  Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).

Authors:  Jen-Ruei Chen; Ting-Chang Chang; Hung-Chun Fu; Hei-Yu Lau; I-Hui Chen; Yu-Min Ke; Yu-Ling Liang; An-Jen Chiang; Chia-Yen Huang; Yu-Chieh Chen; Mun-Kun Hong; Yu-Chi Wang; Kuo-Feng Huang; Sheng-Mou Hsiao; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.